NVWM LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.74M | Buy |
13,654
+35
| +0.3% | +$4.37K | 0.39% | 78 |
|
|
2025
Q4 | $1.66M | Sell |
13,619
-303
| -2% | -$34.7K | 0.36% | 80 |
|
|
2025
Q3 | $1.39M | Buy |
13,922
+235
| +2% | +$21.2K | 0.31% | 93 |
|
|
2025
Q2 | $1.14M | Buy |
13,687
+514
| +4% | +$41K | 0.27% | 112 |
|
|
2025
Q1 | $1.07M | Buy |
13,173
+1,344
| +11% | +$120K | 0.28% | 106 |
|
|
2024
Q4 | $1.07M | Sell |
11,829
-858
| -7% | -$83.1K | 0.27% | 110 |
|
|
2024
Q3 | $1.25M | Buy |
12,687
+83
| +0.7% | +$8.15K | 0.32% | 95 |
|
|
2024
Q2 | $1.17M | Buy |
12,604
+6,465
| +105% | +$580K | 0.31% | 96 |
|
|
2024
Q1 | $583K | Buy |
6,139
+1,361
| +28% | +$126K | 0.16% | 160 |
|
|
2023
Q4 | $427K | Sell |
4,778
-320
| -6% | -$23.8K | 0.13% | 169 |
|
|
2023
Q3 | $372K | Buy |
5,098
+57
| +1% | +$4.55K | 0.12% | 169 |
|
|
2023
Q2 | $419K | Buy |
5,041
+102
| +2% | +$8.53K | 0.14% | 170 |
|
|
2023
Q1 | $376K | Sell |
4,939
-11,325
| -70% | -$940K | 0.13% | 180 |
|
|
2022
Q4 | $1.35M | Sell |
16,264
-2,225
| -12% | -$180K | 0.49% | 61 |
|
|
2022
Q3 | $1.47M | Buy |
18,489
+13,331
| +258% | +$1.12M | 0.58% | 53 |
|
|
2022
Q2 | $384K | Sell |
5,158
-2,429
| -32% | -$182K | 0.15% | 161 |
|
|
2022
Q1 | $682K | Buy |
7,587
+762
| +11% | +$70.4K | 0.22% | 149 |
|
|
2021
Q4 | $764K | Sell |
6,825
-12
| -0.2% | -$1.45K | 0.24% | 145 |
|
|
2021
Q3 | $860K | Buy |
6,837
+186
| +3% | +$24K | 0.31% | 128 |
|
|
2021
Q2 | $901K | Buy |
6,651
+548
| +9% | +$72K | 0.32% | 118 |
|
|
2021
Q1 | $828K | Sell |
6,103
-60
| -1% | -$8.98K | 0.33% | 119 |
|
|
2020
Q4 | $868K | Sell |
6,163
-22
| -0.4% | -$2.82K | 0.36% | 97 |
|
|
2020
Q3 | $690K | Buy |
6,185
+6,173
| +51,442% | +$692K | 0.32% | 102 |
|
|
2020
Q2 | $1K | Hold |
12
| – | – | ﹤0.01% | 337 |
|
|
2020
Q1 | $1K | Hold |
12
| – | – | ﹤0.01% | 314 |
|
|
2019
Q4 | $1K | Sell |
12
-175
| -94% | -$15.1K | ﹤0.01% | 305 |
|
|
2019
Q3 | $14K | Sell |
187
-28
| -13% | -$2.33K | 0.01% | 251 |
|
|
2019
Q2 | $19K | Sell |
215
-150
| -41% | -$12.8K | 0.01% | 255 |
|
|
2019
Q1 | $33K | Sell |
365
-34
| -9% | -$2.89K | 0.02% | 197 |
|
|
2018
Q4 | $29K | Sell |
399
-22,271
| -98% | -$1.79M | 0.02% | 201 |
|
|
2018
Q3 | $2.17M | Buy |
22,670
+1,039
| +5% | +$101K | 1.37% | 14 |
|
|
2018
Q2 | $2.06M | Buy |
21,631
+526
| +2% | +$48.3K | 1.43% | 14 |
|
|
2018
Q1 | $1.77M | Buy |
21,105
+14,336
| +212% | +$1.31M | 1.29% | 18 |
|
|
2017
Q4 | $574K | Buy |
+6,769
| New | +$567K | 0.44% | 71 |
|
Other funds holding XBI
NVWM LLC's XBI Position: Q1 2026 in Review
NVWM LLC increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.26% in Q1 2026, buying an estimated $4.37K and bringing the position to 13,654 shares worth $1.74M. The position accounts for 0.39% of the portfolio, ranked #78.
NVWM LLC first reported a position in XBI in Q4 2017 and has held it in 34 quarters since. The position peaked at $2.17M in Q3 2018. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- NVWM LLC held 13,654 shares of State Street SPDR S&P Biotech ETF worth $1.74M as of Q1 2026.
- NVWM LLC bought 35 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $4.37K.
- State Street SPDR S&P Biotech ETF made up 0.39% of NVWM LLC's portfolio in Q1 2026, its #78 holding.
- NVWM LLC first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and has held it in 34 quarters since.
- NVWM LLC's State Street SPDR S&P Biotech ETF position peaked at $2.17M in Q3 2018.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on NVWM LLC's 13F filing for Q1 2026, filed 27 Apr 2026.